November 14, 2025

Big sex differences found in how diet and insulin rewire muscle for better blood sugar

November 14, 2025 / Research update / InnovateMed Author / insulin

by University of Michigan edited by Gaby Clark, reviewed by Robert Egan Credit: i-SENS, USA from Pexels New research found that restricting calories dramatically rewires proteins in rat skeletal muscle, causing molecular changes that boost insulin sensitivity—crucial for blood sugar control in older adults, say scientists at the University of Michigan and the University of Sydney. Surprisingly, roughly […]

Big sex differences found in how diet and insulin rewire muscle for better blood sugar Read More »

Hypertension affects the brain much earlier than expected, study suggests

November 14, 2025 / Research update / InnovateMed Author / hypertension

by Weill Cornell Medical College edited by Gaby Clark, reviewed by Robert Egan Editors’ notes In the brain cortex of mice (left) without hypertension, few endothelial cells (yellow) show aging or senescence (blue). After angiotensin is administered, which causes hypertension (middle), many more endothelial cells (blue) with aging and damage are present in the cortex. Blocking angiotensin receptors

Hypertension affects the brain much earlier than expected, study suggests Read More »

How weakness in cell structure affects the host–microbiome relationship

November 14, 2025 / Research update / InnovateMed Author / cell structure

by The Francis Crick Institute edited by Lisa Lock, reviewed by Robert Egan Editors’ notes ‘Swiss roll’ guts from a heathy mouse (left) and an ARPC5-deficient mouse (right). Credit: Science (2025). DOI: 10.1126/science.adr9571 Cells have an internal skeleton that maintains their structure and also drives their movement. Known as the cytoskeleton, this scaffold is composed of a network of dynamic

How weakness in cell structure affects the host–microbiome relationship Read More »

Reversing fibrosis: New research provides insight for novel therapies

November 14, 2025 / Research update / InnovateMed Author / reversing fibrosis

by Isabella Backman, Yale School of Medicine edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Model of keratinocyte-derived high affinity EGFR ligands to activate EGFR-STAT1 signaling in profibrotic fibroblasts. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-64648-9 Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease.

Reversing fibrosis: New research provides insight for novel therapies Read More »

Study by Incheon National University could transform skin cancer detection with near-perfect accuracy

November 14, 2025 / Research update / InnovateMed Author / cancer detection

New deep learning system integrates images and clinical details, improving early skin cancer diagnosis and aiding in smart healthcare Peer-Reviewed Publication Incheon National University Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they often

Study by Incheon National University could transform skin cancer detection with near-perfect accuracy Read More »

Research progress on leptin in metabolic dysfunction-associated fatty liver disease

November 14, 2025 / Research update / InnovateMed Author / fatty liver disease

Xia & He Publishing Inc. Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with obesity, type 2 diabetes (T2DM), and metabolic syndrome. Its pathogenesis is complex, following a “multiple-hit” hypothesis that involves triglyceride accumulation, insulin resistance (IR), lipotoxicity, chronic inflammation, and oxidative stress. Among the various

Research progress on leptin in metabolic dysfunction-associated fatty liver disease Read More »

Pill-induced esophagitis: Why your medication could be damaging your throat and what to do about it

November 14, 2025 / Patient education / InnovateMed Author / pill induced esophagitis

by Adam Taylor, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Pills. Credit: Public Domain Every year, people around the world take an astonishing 3.8 trillion doses of medicine. Most of these medicines are swallowed rather than injected or inhaled, because the oral route is the easiest, safest and most familiar way to take

Pill-induced esophagitis: Why your medication could be damaging your throat and what to do about it Read More »

New pill cuts ‘bad’ cholesterol by 60%, potentially replacing injections

November 14, 2025 / Research update / InnovateMed Author / new pill

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections. The drug, called enlicitide, slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs already on the market. The pill blocks a liver protein called PCSK9, which

New pill cuts ‘bad’ cholesterol by 60%, potentially replacing injections Read More »

New gene discoveries improve diagnosis of inherited heart disease

November 14, 2025 / Research update / InnovateMed Author / heart disease

by Tony Crawshaw, The Centenary Institute edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes Credit: Dimitri Dim from Pexels Centenary Institute researchers have uncovered new genetic causes of inherited heart conditions, providing families with vital answers to guide treatment and prevention. Inherited heart conditions affect more than one in every 200 Australians and are a major

New gene discoveries improve diagnosis of inherited heart disease Read More »

Two drugs that treat prostate cancer may also be effective against leukemia

November 14, 2025 / Research update / InnovateMed Author / leukemia

by Katie Bohn, Pennsylvania State University edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes Credit: Blood Advances (2025). DOI: 10.1182/bloodadvances.2024012639 Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood and bone

Two drugs that treat prostate cancer may also be effective against leukemia Read More »